Detalhe da pesquisa
1.
Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
Haematologica
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855051
2.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw
; 21(11): 1118-1131, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935098
3.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw
; 19(11): 1218-1230, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781267
4.
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
Blood
; 132(10): 1013-1021, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049811
5.
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.
J Natl Compr Canc Netw
; 17(6): 650-661, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200358
6.
Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.
Cancer
; 123(24): 4851-4859, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841236
7.
Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study.
Br J Haematol
; 173(2): 283-91, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26913697
8.
Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405).
Blood
; 123(11): 1665-73, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24458437
9.
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
Am J Hematol
; 91(3): 308-12, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26662208
10.
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Blood Adv
; 7(21): 6381-6394, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171397
11.
VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study.
Br J Haematol
; 155(2): 190-7, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21848883
12.
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.
Clin Cancer Res
; 26(17): 4468-4477, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32532790
13.
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
J Clin Oncol
; 37(21): 1790-1799, 2019 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30939090
14.
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma.
Clin Lymphoma Myeloma
; 8(3): 153-8, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18650178
15.
VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.
Clin Lymphoma Myeloma Leuk
; 18(1): e61-e67, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191715
16.
Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).
Blood Adv
; 2(14): 1705-1718, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030269
17.
Therapeutic advances in the treatment of brain metastases.
Clin Adv Hematol Oncol
; 5(1): 54-64, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17339829
18.
Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Clin Adv Hematol Oncol
; 5(11): 894-902, 907-15, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18185489
19.
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Clin Cancer Res
; 23(5): 1167-1176, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601593
20.
PI3-kinase inhibitors in chronic lymphocytic leukemia.
Curr Hematol Malig Rep
; 9(1): 33-43, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24390602